Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 19, 2023 18:24 ET | Source: Kaplan Fox & Kilsheimer LLP

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Alert: Kaplan Fox & Kilsheimer LLP Notifies Y-mAbs Investors of a Class Action Lawsuit and Upcoming Lead Plaintiff Deadline

NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc....